Disease-modifying treatment (DMT) modelling tool launched to unpick the true cost of MS care

3 December, 2018 | Posted in:

A new tool has been launched which models the true financial and workforce resources needed to safely provide disease-modifying therapies (DMTs) to people living with multiple sclerosis (MS). DMTs are an effective means of treating relapsing-remitting MS, the most common form of the condition, reducing the frequency of relapses and the build-up of lesions in […]

Continue Reading »